Evaluation of Parkinson disease and Alzheimer disease with the use of neuromelanin MR imaging and (123)I-metaiodobenzylguanidine scintigraphy. (Q53452154)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Evaluation of Parkinson disease and Alzheimer disease with the use of neuromelanin MR imaging and (123)I-metaiodobenzylguanidine scintigraphy. |
scientific article |
Statements
Evaluation of Parkinson disease and Alzheimer disease with the use of neuromelanin MR imaging and (123)I-metaiodobenzylguanidine scintigraphy. (English)
1 reference
F Miyoshi
1 reference
T Ogawa
1 reference
S-i Kitao
1 reference
M Kitayama
1 reference
M Takasugi
1 reference
S Fujii
1 reference
T Kaminou
1 reference
6 June 2013
1 reference
34
1 reference
11
1 reference
2113-2118
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference